Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

被引:5
作者
Ng, Hoi Man [1 ]
Lei, Chon Lok [2 ]
Fu, Siyi [2 ]
Li, Enqin [2 ]
Leong, Sek In [1 ]
Nip, Chu Iong [1 ]
Choi, Nga Man [1 ]
Lai, Kai Seng [1 ]
Tang, Xi Jun [3 ]
Lei, Chon Leng [1 ]
Xu, Ren-He [2 ]
机构
[1] Kiang Wu Hosp, Lab Dept, Macau, Peoples R China
[2] Univ Macau, Fac Hlth Sci, Macau, Peoples R China
[3] Zhuhai Hosp Combined Tradit Chinese & Western Med, Lab Dept, Zhuhai, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
SARS-CoV-2; inactivated vaccine; mRNA vaccine; heterologous vaccinations; antibodies; spike proteins; nucleocapsid proteins; Macao;
D O I
10.3389/fimmu.2023.1131985
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mRNA vaccines (RVs) can reduce the severity and mortality of severe acute respiratory syndrome coronavirus (SARS-CoV-2). However, almost only the inactivated vaccines (IVs) but no RVs had been used in mainland China until most recently, and the relaxing of its anti-pandemic strategies in December 2022 increased concerns about new outbreaks. In comparison, many of the citizens in Macao Special Administrative Region of China received three doses of IV (3IV) or RV (3RV), or 2 doses of IV plus one booster of RV (2IV+1RV). By the end of 2022, we recruited 147 participants with various vaccinations in Macao and detected antibodies (Abs) against the spike (S) protein and nucleocapsid (N) protein of the virus as well as neutralizing antibodies (NAb) in their serum. We observed that the level of anti-S Ab or NAb was similarly high with both 3RV and 2IV+1RV but lower with 3IV. In contrast, the level of anti-N Ab was the highest with 3IV like that in convalescents, intermediate with 2IV+1RV, and the lowest with 3RV. Whereas no significant differences in the basal levels of cytokines related to T-cell activation were observed among the various vaccination groups before and after the boosters. No vaccinees reported severe adverse events. Since Macao took one of the most stringent non-pharmaceutical interventions in the world, this study possesses much higher confidence in the vaccination results than many other studies from highly infected regions. Our findings suggest that the heterologous vaccination 2IV+1RV outperforms the homologous vaccinations 3IV and 3RV as it induces not only anti-S Ab (to the level as with 3RV) but also anti-N antibodies (via the IV). It combines the advantages of both RV (to block the viral entry) and IV (to also intervene the subsequent pathological processes such as intracellular viral replication and interference with the signal transduction and hence the biological functions of host cells).
引用
收藏
页数:7
相关论文
共 50 条
[41]   Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants [J].
Zhang, Yuntao ;
Zheng, Xiaotong ;
Sheng, Wang ;
Liang, Hongyang ;
Zhao, Yuxiu ;
Zhu, Xiujuan ;
Yang, Rong ;
Zhang, Yadan ;
Dong, Xiaofei ;
Li, Weidong ;
Pei, Fei ;
Ding, Ling ;
Chang, Zhen ;
Deng, Li ;
Yuan, Guangying ;
Yang, Zhaona ;
Zhu, Di ;
Yang, Xiaoming ;
Wang, Hui .
VACCINES, 2022, 10 (08)
[42]   The spike 486 site is a key immune evasion point and a determinant of the immunogenicity of the RBD-dimer mRNA vaccine against SARS-CoV-2 variants [J].
Feng, Simin ;
Huang, Mengting ;
Quan, Yun ;
Sun, Lei ;
Lin, Jinzhong ;
Zhang, Danyang ;
Wei, Xuepeng ;
Wang, Zhongfang ;
Ma, Xiancai ;
Wang, Shaobo ;
Pan, Qianyu ;
Jia, Weixin ;
Wei, Dandan ;
Feng, Guangxue ;
Xu, Menghan ;
Deng, Zengqin ;
Zhang, Qiong .
VIROLOGY, 2025, 610
[43]   Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study [J].
Abdoli, Asghar ;
Aalizadeh, Reza ;
Aminianfar, Hossein ;
Kianmehr, Zahra ;
Teimoori, Ali ;
Azimi, Ebrahim ;
Emamipour, Nabbi ;
Eghtedardoost, Marzieh ;
Siavashi, Vahid ;
Jamshidi, Hamidreza ;
Hosseinpour, Mohammadreza ;
Taqavian, Mohammad ;
Jalili, Hasan .
REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (03)
[44]   Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2 [J].
Jbeli, Rim ;
Jelassi, Awatef .
EURO-MEDITERRANEAN JOURNAL FOR ENVIRONMENTAL INTEGRATION, 2021, 6 (02)
[45]   Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants [J].
Liu, Cong ;
Rcheulishvili, Nino ;
Shen, Zhigao ;
Papukashvili, Dimitri ;
Xie, Fengfei ;
Wang, Ziqian ;
Wang, Xingyun ;
He, Yunjiao ;
Wang, Peng George .
PHARMACEUTICS, 2022, 14 (05)
[46]   RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants [J].
Liang, Qingtai ;
Wang, Yifeng ;
Zhang, Shuyuan ;
Sun, Jing ;
Sun, Wenbo ;
Li, Jizhou ;
Liu, Yaping ;
Li, Mingxi ;
Cheng, Lin ;
Jiang, Yuhang ;
Wang, Ruoke ;
Zhang, Rui ;
Yang, Zihan ;
Ren, Yifei ;
Chen, Peng ;
Gao, Peng ;
Yan, Huayuan ;
Zhang, Zheng ;
Zhang, Qi ;
Shi, Xuanling ;
Wang, Jianbin ;
Liu, Wanli ;
Wang, Xinquan ;
Ying, Bo ;
Zhao, Jincun ;
Qi, Hai ;
Zhang, Linqi .
ISCIENCE, 2022, 25 (04)
[47]   Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice [J].
Liu, Mei-Qin ;
Jiang, Ren-Di ;
Guo, Jing ;
Chen, Ying ;
Yang, Dong-Sheng ;
Wang, Xi ;
Lin, Hao-Feng ;
Li, Ang ;
Li, Bei ;
Hu, Ben ;
Wang, Ze-Jun ;
Yang, Xing-Lou ;
Shi, Zheng-Li .
JOURNAL OF VIROLOGY, 2022, 96 (08)
[48]   A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters [J].
Wu, Yangtao ;
Huang, Xiaofen ;
Yuan, Lunzhi ;
Wang, Shaojuan ;
Zhang, Yali ;
Xiong, Hualong ;
Chen, Rirong ;
Ma, Jian ;
Qi, Ruoyao ;
Nie, Meifeng ;
Xu, Jingjing ;
Zhang, Zhigang ;
Chen, Liqiang ;
Wei, Min ;
Zhou, Ming ;
Cai, Minping ;
Shi, Yang ;
Zhang, Liang ;
Yu, Huan ;
Hong, Junping ;
Wang, Zikang ;
Hong, Yunda ;
Yue, Mingxi ;
Li, Zonglin ;
Chen, Dabing ;
Zheng, Qingbing ;
Li, Shaowei ;
Chen, Yixin ;
Cheng, Tong ;
Zhang, Jun ;
Zhang, Tianying ;
Zhu, Huachen ;
Zhao, Qinjian ;
Yuan, Quan ;
Guan, Yi ;
Xia, Ningshao .
SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (606)
[49]   Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity [J].
Vallejo, Alejandro ;
Martin-Hondarza, Adrian ;
Gomez, Sandra ;
Velasco, Hector ;
Vizcarra, Pilar ;
Haemmerle, Johannes ;
Casado, Jose L. .
FRONTIERS IN MICROBIOLOGY, 2022, 12
[50]   Quantitative and qualitative analysis of seroconversion after one year of vaccination with inactivated SARS-CoV-2 vaccine (CoronaVac®) in healthcare workers: Cross-sectional analytical study [J].
da Silva, Julia Gomes ;
Arruk, Viviana Galimberti ;
Luciano da Veiga, Glaucia Raquel ;
de Alcantara Sousa, Luiz Vinicius ;
Aguiar Alves, Beatriz da Costa ;
Affonso Fonseca, Fernando Luiz ;
van der Heijden Natario, Inneke Marie .
JOURNAL OF VIROLOGICAL METHODS, 2025, 332